Peripheral Artery Disease (PAD) & Vascular Repair Protocol
Peripheral Artery Disease (PAD) & Vascular Repair Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A protocol for patients with peripheral artery disease targeting therapeutic angiogenesis, collateral vessel development, ischemic muscle protection, and peripheral vasodilation to improve walking distance and limb perfusion.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Peripheral Artery Disease (PAD) & Vascular Repair Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Ongoing; monitor ankle-brachial index (ABI) and 6-minute walk distance every 3 months; vascular surgery coordination required for advanced disease
Target Audience
Adults with confirmed PAD, claudication, or critical limb ischemia under vascular medicine supervision
| Compound | Dose | Frequency |
|---|---|---|
| Thymosin Beta-4 Thymosin Beta-4: potent angiogenic peptide; promotes VEGF-A expression and endothelial cell migration; direct stimulation of collateral vessel formation in ischemic limbs | 1.5 mg | Daily SC |
| BPC-157 BPC-157: activates NO synthase for endothelium-dependent vasodilation; stimulates collateral vessel growth in ischemic tissue; reduces endothelial inflammation | 250 mcg | Twice daily SC |
| TB-500 TB-500: systemic angiogenic mobilization; promotes actin polymerization in endothelial cells required for capillary sprouting | 2.5 mg | Twice weekly SC |
| AICAR AICAR: activates HIF-1alpha; drives transcription of VEGF, angiopoietin, and EPO in ischemic muscle; accelerates collateral vessel maturation | 50 mg | Daily SC |
| VIP VIP: peripheral vasodilator via cAMP/cGMP; acutely reduces peripheral vascular resistance to improve claudication walking distance | 50-100 mcg | Daily SC during symptomatic flares |
| Ipamorelin Ipamorelin: preserves ischemic limb muscle mass against vascular-insufficiency atrophy; maintains functional capacity for walking therapy | 100-200 mcg | Daily SC |
Free Peptide Guide
Peripheral Artery Disease (PAD) & Vascular Repair Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Thymosin Beta-4 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Peripheral Artery Disease (PAD) & Vascular Repair Protocol run before reassessment?
A common window is Ongoing; monitor ankle-brachial index (ABI) and 6-minute walk distance every 3 months; vascular surgery coordination required for advanced disease, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Thymosin Beta-4 + BPC-157 execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Peripheral artery disease represents progressive arterial stenosis with consequent limb ischemia, claudication, and risk of critical limb-threatening ischemia. Therapeutic angiogenesis — stimulating new blood vessel formation — is the holy grail of PAD treatment. TB-500 (Thymosin Beta-4) is a potent inducer of VEGF-A and angiogenic signaling, promoting endothelial migration and capillary formation. BPC-157 activates the nitric oxide pathway to produce endothelium-dependent vasodilation and stimulates collateral vessel development in ischemic tissue. AICAR activates HIF-1α, which drives transcription of multiple pro-angiogenic genes. VIP provides peripheral vasodilation to acutely improve blood flow to ischemic limbs. Thymosin Beta-4 (separately administered) has direct angiogenic and anti-apoptotic effects in ischemic endothelium. Ipamorelin maintains muscle mass in ischemic limbs where atrophy accelerates disease progression.
Clinical Research
No clinical references were provided for this stack yet.
More Cardiovascular Health Stacks
Cardiac Health & Heart Peptide Protocol
Comprehensive cardiac protection stack combining GH secretagogue-mediated cardioprotection, peptide cytoprotection, mitochondrial preservation, and tissue-protective receptor activation.
Cardiovascular Health & Atherosclerosis Prevention Protocol
Cardioprotective peptide protocol targeting endothelial function, plaque stabilization, myocardial protection, and reduction of cardiovascular inflammation in at-risk adults.
Heart Failure & Cardiac Rehabilitation Protocol
A comprehensive adjunctive protocol for heart failure patients and cardiac rehabilitation participants, targeting myocardial energetics, cardiac fibrosis, vascular function, and the autonomic dysregulation that perpetuates heart failure progression.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Peripheral Artery Disease (PAD) & Vascular Repair Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.